 |
recombinant human CD24FcIg (humanized fusion protein consisting of the extracellular domain of CD24 linked to IgG1 Fc domain |
|---|---|
| Trade Name | |
| Orphan Indication | Graft Versus Host Disease |
| USA Market Approval | USA |
| USA Designation Date | 2015-06-09 00:00:00 |
| Sponsor | OncoImmune, Inc.;502 E Street, NE;Washington, District of Columbia, 20002 |
